Life Science Company
Merck has acquired 28 companies, including 15 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 6 assets.
Merck’s largest acquisition to date was in 2009, when it acquired Schering-Plough for $41.1B. It’s largest disclosed sale occurred in 2009, when it sold Merial to Sanofi SA for $4.0B. Merck has acquired in 10 different US states, and 7 countries. The Company’s most targeted sectors include life science (89%) and information technology (4%).
Join Mergr and gain access to Merck’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity33
- M&A Buy Activity27
- M&A Sell Activity6
- Total Sectors Invested 4
- Total Countries Invested 7
- M&A Buy/Sell Connections 15
- M&A Advisors 10
Unlimited Searches
